Skip to main content

Closed

MDGL: Madrigal Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

53thpctl

Volume

2.24×avg

Market Cap

10.77BUSD

P/E Ratio

-42.4TTM

Div Yield

-ann

Madrigal Pharmaceuticals, Inc.

MDGLNASDAQ Global Select·USD·Closed

Madrigal Pharmaceuticals, Inc.

MDGLNASDAQ·USD·Closed

$467.32

−5.23%

$467.32

−$25.79 (5.23%)

52W Range

53thpctl

Volume

2.24×avg

Mkt Cap

10.77BUSD

P/E

-42.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings